Business
6 reasons CSL (ASX:CSL) shares are struggling
CSL Limited (ASX: CSL) shareholders have been tearing their hair out over the past 12 months.
The stock price has plummeted 20% during a time the rest of the market has climbed onwards and upwards from the depths of the COVID-19 crash.
It’s been a rude shock for a stock that grew spectacularly for 25 years before the pandemic.
“It took the better part of the past 2.5 decades, but Australian investors eventually warmed to Australia’s largest and most successful biotech company,” FNArena editor Rudi Filapek-Vandyck said to his subscribers.
“Just when it seemed nothing could ever possibly go wrong for Australia’s number one business success story, it somehow did.”
Its life as an ASX-listed company has been so charmed…
-
Noosa News22 hours agoQld prepares for hot, windy weekend with high fire danger at Birdsville Races
-
Noosa News20 hours agoBrisbane news LIVE updates: Tributes for young Brisbane skier Sean Forrest who died at Thredbo | Reece Walsh delivers Broncos’ warning in triumph over Storm
-
Business21 hours agoHow to invest your first $3,000 in the ASX this month
-
Noosa News21 hours agoPiccardi Fry Lawyers – Proctor